Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors
Recently, several panels using two representative targeting methods have been developed but they do not reflect racial specificity, especially for Asians. We have developed and analytically validated the Korean Pan-cancer Companion Diagnostic (CDX) Panel to apply targeted anticancer drugs to Korean...
Main Authors: | Byung-Joo Min, Woo Seung Lee, Myung-Eui Seo, Kye-Hwa Lee, Seung-Yong Jeong, Ja-Lok Ku, Yeul Hong Kim, Sang-Won Shin, Ju Han Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/20/5112 |
Similar Items
-
Lessons from clinical implementation of a preemptive pharmacogenetic panel as part of a testing pilot program with an employer-sponsored medical plan
by: Madeline Norris, et al.
Published: (2023-08-01) -
Comprehensive in vitro and in silico assessments of metabolic capabilities of 24 genomic variants of CYP2C19 using two different substrates
by: Myung-Eui Seo, et al.
Published: (2023-01-01) -
Calculation of the pharmacogenomics benefit score for patients with medication-related problems
by: Thomas M. Polasek, et al.
Published: (2023-05-01) -
Multi-Omics Alleviates the Limitations of Panel Sequencing for Cancer Drug Response Prediction
by: Artem Baranovskii, et al.
Published: (2022-11-01) -
Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates
by: Zeina N. Al-Mahayri, et al.
Published: (2022-09-01)